<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-16855</identifier>
<setSpec>0300-2896</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">The use of levofloxacin for the empirical treatment of exacerbations of mild , chronic COPD: Is it justifie in under-35-years-old patientes with no comorbidity?</dc:title>
<dc:creator>Martínez Benazet, J</dc:creator>
<dc:creator>Casal, J</dc:creator>
<dc:creator>Roig, J</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">No disponible</dc:description>
<dc:source>Arch Bronconeumol;38(11): 547-547, nov. 2002.</dc:source>
<dc:identifier>ibc-16855</dc:identifier>
<dc:title xml:lang="es">¿Está justificada la inclusión de levofloxacino en el tratamiento antibiótico empírico de las exacerbaciones de la enfermedad pulmonar obstructiva crónica leve, en pacientes sin comorbilidad y menores de 65 años?</dc:title>
<dc:subject>^d12561</dc:subject>
<dc:subject>^d23786</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d36008</dc:subject>
<dc:subject>^d903</dc:subject>
<dc:type>article</dc:type>
<dc:date>200211</dc:date>
</metadata>
</record>
</ibecs-document>
